Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01303
|
|||||
| Drug Name |
Guanidine
|
|||||
| Synonyms |
(NH2)2C=NH; 4-03-00-00148 (Beilstein Handbook Reference); AC1L1G4E; AC1Q50DT; AC1Q50DU; Aminoformamidine; Aminomethanamidine; Carbamamidine; Carbamidine; GAI; Gu; Guanidin; Guanidine, Hydrochloride; Guanidine, free base;BRN 0506044; H2N-C(=NH)-NH2; HSDB 7603; Imidourea; Iminourea; JU58VJ6Y3B; NCIOpen2_007946; UNII-JU58VJ6Y3B; ZRALSGWEFCBTJO-UHFFFAOYSA-N; guanidine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Myasthenic syndrome [ICD11: 8C62] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
CH5N3
|
|||||
| Canonical SMILES |
C(=N)(N)N
|
|||||
| InChI |
InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)
|
|||||
| InChIKey |
ZRALSGWEFCBTJO-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 113-00-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 59.07 | Topological Polar Surface Area | 75.9 | ||
| Heavy Atom Count | 4 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
-1.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:42820
|
|||||
| DT(s) Transporting This Drug | OCT-3 | Transporter Info | Organic cation transporter 3 | Substrate | [1] | |
| References | ||||||
| 1 | Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol. 2000 Sep;279(3):F449-58. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.